###begin article-title 0
Angiotensin-Converting Enzyme I/D Polymorphism and Preeclampsia Risk: Evidence of Small-Study Bias
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 192 201 192 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ACE-I/D)</italic>
###xml 337 344 337 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Inappropriate activation of the renin-angiotensin system may play a part in the development of preeclampsia. An insertion/deletion polymorphism within the angiotensin-I converting enzyme gene (ACE-I/D) has shown to be reliably associated with differences in angiotensin-converting enzyme (ACE) activity. However, previous studies of the ACE-I/D variant and preeclampsia have been individually underpowered to detect plausible genotypic risks.
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 228 235 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 417 424 417 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 549 556 549 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 605 606 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 655 662 655 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 81 86 <span type="species:ncbi:9606">women</span>
A prospective case-control study was conducted in 1,711 unrelated young pregnant women (665 preeclamptic and 1,046 healthy pregnant controls) recruited from five Colombian cities. Maternal blood was obtained to genotype for the ACE-I/D polymorphism. Crude and adjusted odds ratio (OR) and 95% confidence interval (CI) using logistic regression models were obtained to evaluate the strength of the association between ACE-I/D variant and preeclampsia risk. A meta-analysis was then undertaken of all published studies to February 2006 evaluating the ACE-I/D variant in preeclampsia. An additive model (per-D-allele) revealed a null association between the ACE-I/D variant and preeclampsia risk (crude OR = 0.95 [95% CI, 0.81-1.10]) in the new case-control study. Similar results were obtained after adjusting for confounders (adjusted per-allele OR = 0.90 [95% CI, 0.77-1.06]) and using other genetic models of inheritance. A meta-analysis (2,596 cases and 3,828 controls from 22 studies) showed a per-allele OR of 1.26 (95% CI, 1.07-1.49). An analysis stratified by study size showed an attenuated OR toward the null as study size increased.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE D</italic>
It is highly likely that the observed small nominal increase in risk of preeclampsia associated with the ACE D-allele is due to small-study bias, similar to that observed in cardiovascular disease. Reliable assessment of the origins of preeclampsia using a genetic approach may require the establishment of a collaborating consortium to generate a dataset of adequate size.
###end p 6
###begin p 7
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE D</italic>
The observed small increase in risk of preeclampsia associated with theACE D-allele is likely to be due to small-study bias, a similar result to that observed in cardiovascular disease.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
###xml 54 59 <span type="species:ncbi:9606">women</span>
###xml 183 188 <span type="species:ncbi:9606">women</span>
###xml 238 243 <span type="species:ncbi:9606">women</span>
###xml 781 786 <span type="species:ncbi:9606">women</span>
Preeclampsia is a common condition affecting pregnant women worldwide; it is defined as the presence of increased blood pressure, together with protein in the urine. Although in many women preeclampsia may never result in symptoms, other women may experience headaches, problems with their vision, swollen ankles and feet, and other problems. Sometimes, preeclampsia progresses to eclampsia, in which potentially life-threatening seizures result. The causes of preeclampsia are not well understood, but several factors are known to contribute to the risk. These factors include diabetes, high blood pressure prior to pregnancy, obesity, and first pregnancy. There is also the possibility that preeclampsia has, at least in part, a genetic basis; the condition is more likely among women whose relatives have also had it. However, no definite genetic cause has yet been confirmed.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE,</italic>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 598 601 598 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 376 388 <span type="species:ncbi:9606">participants</span>
A common variant in one particular gene, ACE, which codes for the angiotensin-1 converting enzyme, has been linked with preeclampsia in a number of different studies. The protein encoded by ACE is involved in controlling blood pressure and the balance of fluid and salts in the blood. However, many of the studies supposedly linking ACE and preeclampsia were done on very few participants. Small studies are more likely to generate "false positive" findings. Therefore, a group of investigators from Colombia and the UK wanted to find out whether they could reproduce the supposed link between the ACE gene variant and preeclampsia in a large study, and also to see whether the previous studies could have been "false positives."
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 584 587 584 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 784 787 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 1181 1184 1181 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 70 75 <span type="species:ncbi:9606">women</span>
###xml 138 143 <span type="species:ncbi:9606">women</span>
###xml 246 251 <span type="species:ncbi:9606">women</span>
###xml 367 378 <span type="species:ncbi:9606">participant</span>
###xml 868 873 <span type="species:ncbi:9606">women</span>
###xml 1140 1145 <span type="species:ncbi:9606">women</span>
###xml 1261 1273 <span type="species:ncbi:9606">participants</span>
These investigators carried out a case-control study. This means that women with preeclampsia ("cases") were recruited, and compared with women similar in all other respects but who did not have preeclampsia ("controls"). In total 1,711 pregnant women from five Colombian cities were studied, of whom 665 had preeclampsia and 1,046 did not. Blood was taken from each participant and used for DNA sequencing of the ACE gene. The investigators then did a statistical comparison to see whether there was any association between preeclampsia and possession of a particular variant of the ACE gene. The results showed that there was no such association. Then, the investigators did a literature search to find all previous studies that had examined a possible link between variants of the ACE gene and preeclampsia. They found 22 studies reporting data obtained from 6,424 women (these figures include the results from the investigators' own case-control study described here). The data from all of these studies were then put together into a combined analysis. This combined analysis did suggest a small increase in the risk of preeclampsia in women with one particular variant in the ACE gene. However, this result was more likely in studies with small numbers of participants. Furthermore, the earliest studies done were most likely to show an effect, with the supposed link disappearing as more and more data were collected.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
###xml 192 204 <span type="species:ncbi:9606">participants</span>
The findings presented here suggest that "small study bias" may explain the discrepancy between the results of the case-control study and the combined analysis. That is, studies involving few participants are less reliable and more likely to produce false-positive results. Therefore, it is possible that the proposed link between ACE gene variants and preeclampsia is a spurious one. The investigators propose that in future, collaborative research networks will be needed to carry out rigorous research on the genetics of preeclampsia. Such initiatives will help to overcome the problem of bias that can arise from small studies.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
###xml 16 24 <span type="species:ncbi:9606">patients</span>
Information for patients from about preeclampsia
###end p 19
###begin p 20
Medical encyclopedia entry on preeclampsia from , supplied by the US National Library of Medicine
###end p 20
###begin p 21
Information from the World Health Organization and Pan American Health Organization on
###end p 21
###begin title 22
Introduction
###end title 22
###begin p 23
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b001">1</xref>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b002">2</xref>
###xml 592 593 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b003">3</xref>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b004">4</xref>
Preeclampsia is a maternal disease of pregnancy associated with increased blood pressure and proteinuria after 20 weeks of gestation. It is a major cause of maternal and neonatal mortality and morbidity worldwide and has particularly high incidence in Latin American and Caribbean countries, in which hypertensive disorders during pregnancy account for 25.7% of maternal deaths [1,2]. Preeclampsia is thought to be the result of the interplay between important genetic components and environmental influences; however, the factors and the mechanisms that lead to preeclampsia remain elusive [3]. As a result, there is a lack of effective preventive interventions [4].
###end p 23
###begin p 24
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b005">5</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b006">6</xref>
###xml 195 200 <span type="species:ncbi:9606">women</span>
With the exception of smoking, established risk factors for cardiovascular disease, including high blood pressure, diabetes, and obesity, are also risk factors for preeclampsia [5]. In addition, women who suffer from preeclampsia have an increased risk of later cardiovascular disease, which clearly suggests a shared aetiology [6].
###end p 24
###begin p 25
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b007">7</xref>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b008">8</xref>
###xml 245 254 245 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ACE-I/D)</italic>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b009">9</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b011">11</xref>
###xml 540 541 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b010">10</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b012">12</xref>
###xml 865 872 865 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 923 930 923 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b013">13</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b016">16</xref>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b013">13</xref>
###xml 1185 1187 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b016">16</xref>
###xml 430 437 <span type="species:ncbi:9606">persons</span>
Inappropriate activation of the renin-angiotensin system may play a part in the development of many cardiovascular disorders, including preeclampsia [7,8]. A common insertion/deletion polymorphism within the angiotensin-I converting enzyme gene (ACE-I/D) has been reliably associated with substantial differences in the plasma and tissue angiotensin-converting enzyme (ACE) activity in a codominant (additive) fashion not only in persons of European descent, but also in other populations such as Hispanics [9-11]. Individuals carrying the D allele have higher ACE activity, which has been proposed as an intermediate phenotype of potential relevance for the development of high blood pressure and subclinical atheroma (i.e., higher intima-media thickness of the carotid artery) [10,12]. Despite the biological plausibility and the consistency of the effect of the ACE-I/D polymorphism on ACE activity, associations of the ACE-I/D polymorphism and coronary heart disease, coronary artery restenosis, stroke, and renal disease have been inconsistent [13-16]. Moreover, systematic reviews and meta-analyses have indicated the presence of small-study bias in the published literature [13-16].
###end p 25
###begin p 26
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 99 106 99 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 282 283 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b008">8</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b017">17</xref>
###xml 337 344 337 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 474 481 474 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 713 720 713 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 882 889 882 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 64 69 <span type="species:ncbi:9606">women</span>
Several studies, also usually small in size, have reported that women carrying the D allele of the ACE-I/D polymorphism have higher ACE activity and higher measures of uterine artery resistance, which is a marker for development of intrauterine growth retardation and preeclampsia [8,17]. These observations led to the proposal that the ACE-I/D polymorphism may be a good candidate in the search for a cause of preeclampsia. However, to date, studies evaluating the role of ACE-I/D polymorphism in preeclampsia have been individually underpowered to detect plausible genetic effect sizes, being much smaller than more recent studies in cardiovascular disease. We hypothesized that the published literature on the ACE-I/D polymorphism in preeclampsia might be similarly affected by small-study bias. To test this hypothesis, we conducted a new large genetic association study on the ACE-I/D polymorphism and preeclampsia in a geographical region with a high incidence of preeclampsia. We then set this study within the context of a systematic review and a meta-analysis of all studies conducted to date.
###end p 26
###begin title 27
Methods
###end title 27
###begin title 28
###xml 19 31 <span type="species:ncbi:9606">Participants</span>
Case-Control Study Participants
###end title 28
###begin p 29
###xml 81 86 <span type="species:ncbi:9606">women</span>
###xml 105 117 <span type="species:ncbi:9606">participants</span>
A prospective case-control study was conducted in 1,711 unrelated young pregnant women (665 preeclamptic participants and 1,046 healthy pregnant controls) recruited from five Colombian cities at the time of delivery between January 2000 and December 2005. A verbal interview with a structured questionnaire was conducted by trained personnel at the time of the delivery to ascertain maternal age, gestational age, parity, smoking status during pregnancy, family history of preeclampsia, ethnic background, and socioeconomic position. On two separate occasions, the mean of two readings of blood pressure was obtained (four measurements in total) at the time of delivery. Blood pressure was measured in the right arm after a five-minute period of rest in a seated position using mercury sphygmomanometers or electronic devices calibrated against a mercury standard.
###end p 29
###begin p 30
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b018">18</xref>
###xml 36 41 <span type="species:ncbi:9606">woman</span>
###xml 474 479 <span type="species:ncbi:9606">woman</span>
###xml 632 637 <span type="species:ncbi:9606">women</span>
###xml 824 836 <span type="species:ncbi:9606">participants</span>
A case was defined as a primigravid woman younger than 26 years old with blood pressure 140/90 mm Hg or above, and proteinuria 0.3 grams or above in 24 hours, or a reading 2+ or above on a dipstick in a random urine determination with no evidence of urinary tract infection after 20 weeks of gestation [18]. At least one control was recruited after each case within a window of 24 hours from the same hospital that provided the cases. A control was defined as a primigravid woman younger than 26 years old without preeclampsia and in labour after 37 weeks of pregnancy. To improve the homogeneity of the phenotype under evaluation, women with a prior history of autoimmune, metabolic (including diabetes or gestational diabetes), renal, or cardiac (including chronic hypertension) diseases were excluded from the study. All participants signed the informed consent document approved by the Ethics Committee from the Universidad Autonoma de Bucaramanga, Colombia.
###end p 30
###begin title 31
DNA extraction and genotyping.
###end title 31
###begin p 32
###xml 174 181 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 273 274 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b009">9</xref>
###xml 354 357 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</italic>
###xml 401 404 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(I)</italic>
###xml 517 519 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ID</italic>
###xml 557 559 551 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ID</italic>
###xml 575 577 569 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DD</italic>
###xml 643 645 637 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ID</italic>
###xml 649 652 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DD,</italic>
###xml 776 777 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 786 788 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b019">19</xref>
###xml 849 860 843 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>
###xml 997 998 991 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 735 747 <span type="species:ncbi:9606">participants</span>
###xml 1323 1335 <span type="species:ncbi:9606">participants</span>
Blood was drawn from the antecubital vein into EDTA and samples stored at -50 degreesC for DNA extraction, using the QIAamp DNA blood mini-kit (QIAGEN, Hilden, Germany). The ACE-I/D polymorphism in intron 16 was detected according to the method described by Rigat, et al. [9]. PCR is known to have a tendency to preferentially amplify the short deletion (D) allele in contrast to the larger insertion (I) allele in a competitive amplification reaction when both alleles are present, as occurs in individuals with the ID genotype. This leads to mistyping of ID individuals as DD in approximately 4%-5% of the samples. To avoid any mistyping of ID as DD, a second PCR amplification using insertion-specific primers was conducted for all participants who were homozygous for the D allele [19]. For a detailed description of the genotyping methods, see Protocol S1. All available DNA samples were genotyped and included in the present report, with no exclusions. For quality control, a random sample (n = 156) was subjected to a second PCR and genotyping to minimize any possible misclassification. The Cohen's kappa value among the samples regenotyped was equal to 0.95 (95% CI [confidence interval], 0.94-0.96), and the error rate was 2.56% (95% CI, 0.70-6.43). Genotyping was conducted blinded to the clinical status of the participants.
###end p 32
###begin title 33
Statistical analysis.
###end title 33
###begin p 34
###xml 82 83 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 203 206 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;</italic>
###xml 206 207 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 289 296 285 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 380 381 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 471 478 467 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 609 611 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b010">10</xref>
###xml 688 690 684 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ID</italic>
###xml 698 700 694 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">II</italic>
###xml 705 707 701 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DD</italic>
###xml 715 717 711 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">II</italic>
To evaluate the presence of differences between groups, unpaired Student's t-, chi2, or Mann-Whitney tests were used as appropriate. A test for departure from Hardy-Weinberg equilibrium was performed by chi2 analysis. The principal a priori hypothesis was that the association between the ACE-I/D polymorphism and preeclampsia follows an additive model according to the number of D alleles. The additive "per-allele" model (in a log-scale) was based on the effect of the ACE-I/D variant on its intermediate phenotype (ACE activity), established in large studies and overviews as being a reliable association [10]. However, recessive and dominant models and multiple pairwise comparisons (ID versus II and DD versus II) were also evaluated for completeness as secondary outcomes.
###end p 34
###begin p 35
###xml 168 173 <span type="species:ncbi:9606">women</span>
Multivariate analysis using logistic regression methods was also conducted to control for potential confounders (maternal age, ethnic background, place of birth of the women, recruitment centre, socioeconomic position, urinary or vaginal infections during pregnancy, and smoking status during pregnancy).
###end p 35
###begin p 36
###xml 81 86 <span type="species:ncbi:9606">women</span>
###xml 168 173 <span type="species:ncbi:9606">women</span>
To explore the prior hypothesis that the genotypic odds ratio (OR) is greater in women with an enriched phenotype, an analysis using an additive model was repeated for women stratified according to the presence of family history of preeclampsia (positive versus negative family history in mother or sisters), and disease severity with severe preeclampsia being defined as blood pressure above 160/110 mm Hg or proteinuria of 5 grams or more in 24 hours, eclampsia, or the HELLP syndrome. For these analyses 99% CIs were used to make some allowance for their exploratory nature. All statistical analyses were conducted using Stata, Version 9 (Stata Corporation, College Station, Texas, United States).
###end p 36
###begin title 37
Meta-Analysis
###end title 37
###begin title 38
Search strategy and selection criteria.
###end title 38
###begin p 39
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 203 209 <span type="species:ncbi:9606">humans</span>
Electronic databases (MEDLINE, EMBASE, LILACS, KoreaMed, and Google Scholar) were searched up to February 2006 for all genetic association studies evaluating the ACE-I/D polymorphism and preeclampsia in humans in all languages. The search strategy contained both medical subject heading terms and text words as follows: "angiotensin-converting enzyme" or "ACE" or "peptidyl-dipeptidase A," in combination with "pre-eclampsia" or "preeclampsia" or "pregnant hypertensive disorders" or "pregnancy hypertension," and combined with "genetic" or "polymorphism(s)" or "mutation" or "genotype" or "gene(s)." No limits were used in the search strategy. We searched for any additional studies in the references of all identified publications, including previous relevant meta-analyses, and used the MEDLINE option "related articles" for all the relevant papers.
###end p 39
###begin p 40
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 48 53 <span type="species:ncbi:9606">women</span>
For inclusion, studies had to involve unrelated women and examine the association between the ACE-I/D polymorphism and preeclampsia. Studies published as full-length articles or letters in peer-reviewed journals in any language were included, as well as abstracts taken from reference lists of identified publications. Authors were contacted (on at least three occasions) to obtain information on the genotype frequency by case-control status and by disease severity (severe and nonsevere preeclampsia), the use of blinding of genotyping staff to clinical status, the definition of outcomes, and, in a few cases, to clarify possible overlapping of study results. A positive reply was obtained in 15 out of 21 study authors contacted.
###end p 40
###begin title 41
Data extraction.
###end title 41
###begin p 42
###xml 370 373 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;</italic>
###xml 373 374 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 430 431 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 468 480 <span type="species:ncbi:9606">participants</span>
###xml 507 512 <span type="species:ncbi:9606">women</span>
###xml 710 715 <span type="species:ncbi:9606">Women</span>
The following information was extracted (entered into databases by two of the authors, JPC and MCP) from each study and disagreements resolved by consensus: year of publication, total cases, total controls, number of individuals by each genotype, study design, source of controls, matching variable, thresholds used to define preeclampsia, country of origin, ethnicity, chi2 goodness of fit for Hardy-Weinberg equilibrium and its p-value, use of blinding, mean age of participants, frequency of nulliparous women, and main exclusion criteria. In the few instances in which genotype frequencies provided by the investigators in tabular data differed slightly from published figures, the tabular data were used. Women with gestational hypertension were excluded from the present meta-analysis in order to improve the homogeneity of phenotype between studies.
###end p 42
###begin title 43
Statistical analysis.
###end title 43
###begin p 44
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b020">20</xref>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Q</italic>
###xml 963 964 963 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 964 965 964 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b020">20</xref>
###xml 2051 2053 2049 2051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b020">20</xref>
###xml 2054 2056 2052 2054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b021">21</xref>
###xml 2182 2184 2180 2182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b020">20</xref>
###xml 1538 1543 <span type="species:ncbi:9606">women</span>
Data were analysed using Stata 9. The genetic model to be considered as the priori hypothesis was an additive model, following the considerations previously described for the case-control study. Secondary analyses involved ORs for other genetic models of inheritance such as recessive, dominant, and pairwise comparisons of the different genotypes. For all the models used, the D allele was considered the one at risk. For the additive or per-allele model, the OR was compared between cases and controls by assigning scores for different genotype groups and calculating ORs by logistic regression. We calculated the random effect summary OR and CIs for each polymorphism. To make some allowance for multiple comparisons 99% CIs were used for individual studies, and 95% CIs were reserved for the combined estimates. The inverse variance-weighted method was used to calculate the summary OR [20]. Heterogeneity was assessed by the DerSimonian and Laird Q test and I2 was used as a measure to describe the percentage of variability in point estimates that was due to heterogeneity rather than sampling error [20]. Sources of between-study heterogeneity were explored using random effect metaregression models with restricted maximum likelihood estimation. The prespecified characteristics for assessment of sources of inter-study heterogeneity were: Study size (number of cases: <100, 100-200, and >/=200); blinding of genotyping staff (blinded, unblinded, or unknown); disease severity (severe versus nonsevere preeclampsia); ethnicity of women evaluated (of European descent, Asian, Hispanic, Afro-Caribbean, and others); preeclampsia definition (adequate versus unclear); and publication language (English- versus non-English-language journals). Funnel plots of the effect estimate against the sample size, Egger regression asymmetry test, and a weighted (by the inverse of the variance of the estimate) linear fixed regression of the log OR against the inverse of the sample size (linear-regression model) were used to evaluate small-study effects [20,21]. To evaluate stability over time of the effect estimate, cumulative meta-analysis using random effect models was conducted [20].
###end p 44
###begin title 45
Results
###end title 45
###begin title 46
Case-Control Study
###end title 46
###begin p 47
###xml 69 76 69 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030520-t001">Table 1</xref>
###xml 207 214 207 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030520-t001">Table 1</xref>
Clinical and demographic data of the cases and controls are shown in Table 1. There were no significant differences in maternal age, ethnic background, and socioeconomic position between cases and controls (Table 1). Expected differences in maternal blood pressure, parity, and newborn weight and condition were recorded.
###end p 47
###begin p 48
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030520-t001">Table 1</xref>
###xml 262 273 262 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 348 355 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 988 995 988 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030520-t002">Table 2</xref>
###xml 1213 1214 1213 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1350 1358 1350 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030520-g001">Figure 1</xref>
###xml 1535 1546 1535 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>
The distribution of the ACE-I/D genotypes and allelic frequencies were not significantly different according to the case-control status (Table 1). Genotype frequencies according to the ethnic group and by recruitment centre are reported in "Appendix Table I" in Protocol S1. An additive model (per-D-allele) revealed a null association between the ACE-I/D variant and preeclampsia risk (crude OR = 0.95 [95% CI, 0.81-1.10]). Adjusting for maternal age, ethnicity, recruitment centre, and place of birth, aimed to minimize the effect of possible population admixture, did not change the estimate of the effect (model-1 OR = 0.92 [95% CI, 0.78-1.07]). A similar result was obtained after further adjustment for additional potential confounders such as socioeconomic position, presence of urinary or vaginal infections during pregnancy, and smoking status during pregnancy (model-2 OR = 0.90 [95% CI, 0.77-1.06]). ORs for other genetic models of inheritance also yielded a null association (Table 2). Pre-specified exploratory subgroup analyses indicated that with the exception of family history of preeclampsia (positive-history OR = 1.30 [99% CI, 0.75-2.26] versus negative-history OR = 0.86 [99% CI, 0.68-1.10]; p-value for heterogeneity equal to 0.07), no substantial heterogeneity of the genetic effect size was observed for any of the subgroups (Figure 1). Additionally, stratified analysis by recruitment centre according to the conformity with Hardy-Weinberg equilibrium yielded similar, null results (see "Appendix Table II" in Protocol S1).
###end p 48
###begin title 49
Meta-Analysis
###end title 49
###begin p 50
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b017">17</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b022">22</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b049">49</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b043">43</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b044">44</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b045">45</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b047">47</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b048">48</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b017">17</xref>
###xml 627 634 627 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b049">49</xref>
###xml 777 785 777 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030520-t301">Tables 3</xref>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030520-t004">4</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b022">22</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b042">42</xref>
###xml 535 540 <span type="species:ncbi:9606">women</span>
###xml 856 868 <span type="species:ncbi:9606">participants</span>
###xml 881 893 <span type="species:ncbi:9606">participants</span>
A total of 30 genetic association studies, including the present study, evaluating the ACE-I/D gene variant and preeclampsia risk were identified [17,22-49]. We excluded eight out of 30 studies for one or more of the following reasons: two in which duplication or partial overlapping of reported data were considered likely [43,44]; three in which the outcome evaluated was solely gestational hypertension [45-47]; one in which relevant data were not reported and could not be obtained from study authors [48]; one that only recruited women with previous preeclampsia [17]; and one in which the sampling frame was based on the ACE-I/D genotype [49]. A total of 22 genetic association studies including 2,596 cases and 3,828 controls were included in the present meta-analysis (Tables 3 and 4) [22-42]. Out of the 22 studies, nine were conducted with Asian participants, eight with participants of European descent, two with African Americans, two with more than one ethnic group, and one with South Asians.
###end p 50
###begin p 51
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 89 97 89 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030520-g002">Figure 2</xref>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 173 174 173 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 187 189 185 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">21</sub>
###xml 184 189 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;<sub>21</sub></italic>
###xml 189 190 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 200 201 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 201 204 199 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 383 391 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>
###xml 566 567 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 563 567 559 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;<sub>2</sub></italic>
###xml 567 568 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 578 579 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 579 582 573 576 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 594 602 588 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>
###xml 734 735 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 731 735 723 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;<sub>2</sub></italic>
###xml 735 736 725 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 746 747 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 747 750 737 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 885 886 873 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 882 886 872 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;<sub>5</sub></italic>
###xml 886 887 874 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 896 897 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 897 900 885 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 1139 1140 1127 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1182 1183 1170 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1343 1352 1331 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0030520-sg001">Figure S1</xref>
###xml 1358 1369 1346 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>
###xml 1848 1857 1836 1845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0030520-sg002">Figure S2</xref>
###xml 1863 1874 1851 1862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>
###xml 1961 1968 1949 1956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030520-t005">Table 5</xref>
The OR under an additive model for preeclampsia was 1.26 (95% CI, 1.07-1.49; p = 0.006) (Figure 2). However, there was evidence of substantial between-study heterogeneity (I2 = 75.1%, chi212 = 84.23, pHet < 0.0001). Study characteristics such as blinding of genotyping staff, publication language, preeclampsia definition, and disease severity explained little of the heterogeneity (Figure 3). A stratified analysis by study size, evaluated as the number of cases in each study (<100, 100-200, and >/=200), showed a diminished effect as the study size increased (chi22 = 16.95, pHet = 0.0002) (Figure 3). Analogous results were obtained when different cutoff points (< 100, 100-500, and >/= 500) for the number of cases were used (chi22 = 18.51, pHet = 0.00009). Similarly, stratifying by ethnicity indicated that studies conducted in Asian populations tended to have a larger ORs (chi52 = 14.4, pHet = 0.007). These findings might be explained by the fact that eight out of the nine studies conducted in Asian populations had fewer than 100 cases in each study. The funnel plot including all studies was asymmetric, and the Egger's test (p = 0.06) and the linear regression model (p = 0.003) suggested the presence of an excess of small studies with more positive results, predominately of studies published in non-English-language journals (Figure S1; see Protocol S1 for details). A cumulative synthesis of ACE-I/D variants and preeclampsia revealed substantial instability of the genetic effect over time, with studies published between 1996 and 1997 demonstrating the most protective effect, immediately followed by studies published in 1998 and 1999 indicating the most significant results in the opposite direction. Then, the effect size is seen to attenuate gradually over time toward a null association with the accumulation of more data (Figure S2; see Protocol S1 for details). Genotypic ORs under other genetic models of inheritance are outlined in Table 5.
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 407 414 407 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
###xml 655 663 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>
###xml 875 876 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 917 918 917 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1406 1408 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b050">50</xref>
###xml 2041 2043 2041 2043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b051">51</xref>
###xml 2296 2298 2296 2298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b052">52</xref>
The current meta-analysis, which includes new data from the largest case-control study to date, represents the most comprehensive evaluation of the ACE-I/D variant in preeclampsia. Although a pooled per-allele OR suggested evidence of an increase in the risk of preeclampsia of 1.26 (95% CI, 1.07-1.49), the robustness of this summary estimate is uncertain. First, our study found a null association of the ACE-I/D variant with preeclampsia. Moreover, there was no substantial evidence of a positive effect in any of the subgroups in the prespecified analyses. Second, the meta-analysis revealed diminishing summary risk estimate as study size increased (Figure 3), regardless of the arbitrary cutoff points used to define the categories. This result is concordant with the results of several statistical tests used to evaluate the presence of small-study bias (Egger's test p = 0.06 and linear-regression model test p = 0.003). Furthermore, since only the published literature was included, it is possible that including unpublished studies (which more often provide evidence of negative or null effects) would have provided additional evidence of small-study bias. Taken together, these findings point to small-study bias as a potential explanation for the results observed in the meta-analysis. Discrepant findings from large and small studies are not new in the field of genetics of complex disorders [50]. When present, discrepancy of genetic effects sizes may be due to multiple causes such as genuine heterogeneity, data manipulation and fabrication, study quality, or publication bias. A form of publication bias relevant to the current report is within-study reporting bias. Because of the facility of measuring multiple genetic markers in a study, significant positive and negative associations (sometimes arising from multiple testing) are more likely to be published early rather than late. Results from the cumulative meta-analysis support this as one possible explanation, which has been referred to as the Proteus phenomenon [51]. Further evidence in support of the presence of within-study reporting bias is the fact that studies published in languages other than English, and in the Asian ethnic group, tend to have larger effects, findings consistent with other recent results [52].
###end p 53
###begin p 54
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b013">13</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b053">53</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b054">54</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b055">55</xref>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b056">56</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b014">14</xref>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b057">57</xref>
###xml 1187 1189 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b054">54</xref>
###xml 1363 1375 <span type="species:ncbi:9606">participants</span>
Publication bias is increasingly being recognized as one of the main threats to the reliability of conclusions drawn from association studies with common disease outcomes. In the setting of cardiovascular and neurological diseases, several positive gene-disease associations, usually based on meta-analysis of small studies, have been subsequently refuted by large genetic studies [13,53]. As a result, several initiatives are now underway to help overcome problems of reporting and publication bias and to help to achieve datasets of appropriate size to detect plausible genetic effects for common disorders, which are likely to require several thousands of cases of the disease (The Wellcome Trust Case Control Consortium, ) [54]. Genetic studies in preeclampsia continue to be somewhat small in size [55,56] and are usually underpowered to detect realistic genotypic relative risks (ORs between 1.15 and 1.4) [14,57]. However, considering the low incidence of preeclampsia (2%-3% in developed countries), it is highly unlikely that a single centre will be able to amass the large number of cases required, and the development of networks of interested investigators may be essential [54]. Therefore, international collaborations, particularly among those countries with a high incidence of preeclampsia, may make recruitment more efficient and help to include participants with different cultural and genetic backgrounds, which can provide further insight into the aetiology of the disease both genetic and/or environmental.
###end p 54
###begin p 55
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b058">58</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b061">61</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b062">62</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b063">63</xref>
###xml 1429 1431 1429 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b054">54</xref>
###xml 1681 1683 1681 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b064">64</xref>
###xml 1751 1753 1751 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030520-b065">65</xref>
Despite these obstacles, the investment in adequate resources to study the genetics of preeclampsia is an important priority. Observational studies and the randomised trials of interventions that have followed have been unsuccessful thus far in identifying causal pathways in preeclampsia amenable to preventive therapies, a clear example of which are the recently failed clinical trials using either antioxidant vitamins or calcium supplements [58-61]. A genetic approach that is less prone to confounding and reverse causation than nongenetic observational studies, may be more likely to identify causal pathways and may help to prioritise therapeutic targets that require evaluation in large and expensive randomised clinical trials [62,63]. The challenge is in how to make better use of the genetic approach in complex diseases such as preeclampsia, in particular to overcome random errors in risk estimates from small studies as well as publication bias. A suggested approach is to establish a collaborating consortium of investigators from existing studies in genetics of preeclampsia to reduce the multiple existing problems such as: (1) inadequate selection of candidate gene variants to be evaluated, (2) biased analyses, and selective reporting of positive results; (3) to promote access to unpublished data; (4) to overcome inadequate outcome definitions; and (5) to provide guidance for developing new large studies [54]. Until such measures are established, it will be important for both authors and journal editors to embrace the publication of both positive and negative results from "well-designed case-control" studies to diminish the problem of publication bias [64]. This approach has recently become a reality for clinical trials [65], and it might help in reducing the temptation of researchers to explore multiple hypotheses in subgroup analyses to obtain one finding of nominal statistical significance that might help acceptance of the paper.
###end p 55
###begin p 56
Investigating the aetiology of preeclampsia, one of the main causes of maternal and neonatal mortality and morbidity worldwide, should be a health research priority. A genetic approach may indeed be useful, but large collaborative studies will also be needed.
###end p 56
###begin title 57
Supporting Information
###end title 57
###begin title 58
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Funnel Plot of Studies of ACE-I/D Polymorphism and Preeclampsia
###end title 58
###begin p 59
ORs for outcome using a per-allele model. Studies in bold are those published in non-English-language journals.
###end p 59
###begin p 60
(38 KB PPT)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin title 62
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Cumulative Synthesis of Studies of ACE-I/D Polymorphism and Preeclampsia
###end title 62
###begin p 63
OR (random effect model) for outcome using a per-allele model.
###end p 63
###begin p 64
(36 KB PPT)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin title 66
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
ACE-I/D Polymorphism and Preeclampsia Risk: Evidence of Small-Study Bias
###end title 66
###begin p 67
(68 KB DOC)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin title 69
Translation of the Abstract into Spanish
###end title 69
###begin p 70
Translation by N. C. Serrano, Universidad Autonoma de Bucaramanga, Bucaramanga, Colombia.
###end p 70
###begin p 71
(25 KB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin title 73
Translation of the Abstract into Chinese
###end title 73
###begin p 74
Translation by D. Wang, Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, United Kingdom.
###end p 74
###begin p 75
(33 KB DOC)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin title 77
Accession Numbers
###end title 77
###begin p 78
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE</italic>
The SNP database () single-nucleotide polymorphism discussed in this paper is an insertion/deletion variant (rs1799752) referenced to the ACE gene with the GenBank () accession number J04144.
###end p 78
###begin p 79
###xml 264 272 <span type="species:ncbi:39367">Rosemary</span>
Thanks to Drs Hideki Watanabe, Linda Morgan, Ioannis Georgiou, Rosanna Abate, Jeong Bae Park, Francois Rousseau, Figen Gurdol, Young Ju Kim, Huai Bai, Tsunenobu Tamura, Vanita Jain, Agnieszka Seremak-Mrozikiewicz, Vladislav S. Baranov, Adriani Oliveira Galao, and Rosemary Pegoraro, who kindly provided additional valuable information from their studies to the meta-analyses.
###end p 79
###begin title 80
Abbreviations
###end title 80
###begin p 81
angiotensin-converting enzyme
###end p 81
###begin p 82
angiotensin- converting enzyme gene
###end p 82
###begin p 83
confidence interval
###end p 83
###begin p 84
odds ratio
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
Geographic variation in the incidence of hypertension in pregnancy
###end article-title 86
###begin article-title 87
WHO analysis of causes of maternal death: A systematic review
###end article-title 87
###begin article-title 88
Pre-eclampsia
###end article-title 88
###begin article-title 89
Strategies to prevent and treat preeclampsia: Evidence from randomized controlled trials
###end article-title 89
###begin article-title 90
Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies
###end article-title 90
###begin article-title 91
Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study
###end article-title 91
###begin article-title 92
Drugs targeting the renin-angiotensin-aldosterone system
###end article-title 92
###begin article-title 93
The role of RAS in the pathogenesis of preeclampsia
###end article-title 93
###begin article-title 94
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
###end article-title 94
###begin article-title 95
ACE gene polymorphism in cardiovascular disease: Meta-analyses of small and large studies in whites
###end article-title 95
###begin article-title 96
Two quantitative trait loci affect ACE activities in Mexican-Americans
###end article-title 96
###begin article-title 97
Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: A meta-analysis
###end article-title 97
###begin article-title 98
Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5,000 cases and 6,000 controls. International Studies of Infarct Survival (ISIS) Collaborators
###end article-title 98
###begin article-title 99
Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18,000 cases and 58,000 controls
###end article-title 99
###begin article-title 100
Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: Meta-analysis of 16 studies
###end article-title 100
###begin article-title 101
Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: A meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects
###end article-title 101
###begin article-title 102
Maternal-fetal flow, negative events, and preeclampsia: Role of ACE I/D polymorphism
###end article-title 102
###begin article-title 103
Working Group on High Blood Pressure in Pregnancy
###end article-title 103
###begin article-title 104
Mistyping ACE heterozygotes
###end article-title 104
###begin article-title 105
Angiotensinogen and angiotensin-I converting enzyme gene variations in Chinese pregnancy induced hypertension
###end article-title 105
###begin article-title 106
Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia
###end article-title 106
###begin article-title 107
Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia
###end article-title 107
###begin article-title 108
A common genetic variant of the angiotensin converting enzyme is associated with both preeclampsia and chronic hypertension [abstract]
###end article-title 108
###begin article-title 109
Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy
###end article-title 109
###begin article-title 110
The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism
###end article-title 110
###begin article-title 111
Insertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia
###end article-title 111
###begin article-title 112
Association of angiotensin-converting enzyme gene polymorphism with pregnancy-induced hypertension
###end article-title 112
###begin article-title 113
###xml 175 180 <span type="species:ncbi:9606">women</span>
Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin-converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women
###end article-title 113
###begin article-title 114
###xml 103 111 <span type="species:ncbi:9606">patients</span>
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and preeclampsia in Japanese patients
###end article-title 114
###begin article-title 115
Implication of an AGT haplotype in a multigene association study with pregnancy hypertension
###end article-title 115
###begin article-title 116
Study on a deletion polymorphism of the angiotensin converting enzyme gene in pregnancy induced hypertension
###end article-title 116
###begin article-title 117
Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies
###end article-title 117
###begin article-title 118
Genetic predisposition to pre-eclampsia: Polymorphism of genes involved in regulation of endothelial functions
###end article-title 118
###begin article-title 119
###xml 120 125 <span type="species:ncbi:9606">women</span>
Hypertension-related gene polymorphisms in pre-eclampsia, eclampsia and gestational hypertension in Black South African women
###end article-title 119
###begin article-title 120
A common genetic variant of the angiotensin converting enzyme (ACE) gene and pregnancy induced hypertensive disorders
###end article-title 120
###begin article-title 121
Polymorphic genotypes of the angiotensin-converting enzyme in severe pregnancy-induced hypertension
###end article-title 121
###begin article-title 122
Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration
###end article-title 122
###begin article-title 123
Relationships between polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase genes and genetic susceptibility to pregnancy-induced hypertension
###end article-title 123
###begin article-title 124
Evidence for an association of the R485K polymorphism in the coagulation factor V gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate genes
###end article-title 124
###begin article-title 125
Detection of insertion/deletion polymorphism of angiotensin converting enzyme gene in preeclampsia
###end article-title 125
###begin article-title 126
###xml 140 145 <span type="species:ncbi:9606">women</span>
A study on the association between angiotensinogen gene and angiotensin-converting-enzyme gene and pregnancy-induced hypertension in Korean women
###end article-title 126
###begin article-title 127
Polymorphism of gene angiotensin converting enzyme in pregnancy induced hypertension
###end article-title 127
###begin article-title 128
Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension
###end article-title 128
###begin article-title 129
Lack of relationship between angiotensinogen gene m235t polymorphism and gene insertion/deletion (I/D-intron 16) and Pst I RFLP (P/M-intron 7) polymorphisms of the angiotensin I converting enzyme (ACE) gene and the development of H-gestosis. Preliminary results
###end article-title 129
###begin article-title 130
Study on a deletion polymorphism of the angiotensin converting enzyme gene in pregnancy induced hypertension
###end article-title 130
###begin article-title 131
Study on the relation between the angiotensin converting enzyme gene and pregnancy induced hypertension
###end article-title 131
###begin article-title 132
###xml 156 161 <span type="species:ncbi:9606">women</span>
Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women
###end article-title 132
###begin article-title 133
Genetic associations in large versus small studies: An empirical assessment
###end article-title 133
###begin article-title 134
Early extreme contradictory estimates may appear in published research: The Proteus phenomenon in molecular genetics research and randomized trials
###end article-title 134
###begin article-title 135
Local literature bias in genetic epidemiology: An empirical evaluation of the Chinese literature
###end article-title 135
###begin article-title 136
UCHL-1 is not a Parkinson's disease susceptibility gene
###end article-title 136
###begin article-title 137
###xml 38 43 <span type="species:ncbi:9606">human</span>
A road map for efficient and reliable human genome epidemiology
###end article-title 137
###begin article-title 138
Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: A case-control study and a meta-analysis
###end article-title 138
###begin article-title 139
Genetic thrombophilias and preeclampsia: A meta-analysis
###end article-title 139
###begin article-title 140
Association study designs for complex diseases
###end article-title 140
###begin article-title 141
Vitamins C and E and the risks of preeclampsia and perinatal complications
###end article-title 141
###begin article-title 142
###xml 36 41 <span type="species:ncbi:9606">women</span>
Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomised placebo-controlled trial
###end article-title 142
###begin article-title 143
###xml 104 109 <span type="species:ncbi:9606">women</span>
World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women
###end article-title 143
###begin article-title 144
Trial of calcium to prevent preeclampsia
###end article-title 144
###begin article-title 145
Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk
###end article-title 145
###begin article-title 146
Nature's randomised trials
###end article-title 146
###begin article-title 147
Journals should publish all "null" results and should sparingly publish "positive" results
###end article-title 147
###begin article-title 148
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy
###end article-title 148
###begin article-title 149
Classification of hypertension in pregnancy
###end article-title 149
###begin article-title 150
National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy (1990)
###end article-title 150
###begin article-title 151
Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy
###end article-title 151
###begin article-title 152
ACOG technical bulletin. Hypertension in pregnancy. Number 219-January 1996 (replaces number 91, February 1986)
###end article-title 152
###begin title 153
Figures and Tables
###end title 153
###begin title 154
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Risk Association of ACE-I/D Variant with Preeclampsia in Selected Subgroups within the Current Study
###end title 154
###begin title 155
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Meta-Analysis of Studies of ACE-I/D Polymorphism and Risk of Preeclampsia
###end title 155
###begin title 156
###xml 11 18 11 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Studies of ACE-I/D Polymorphism and Risk of Preeclampsia Grouped by Study Characteristics
###end title 156
###begin p 157
Maternal and Neonatal Characteristics of the Sample Studied
###end p 157
###begin p 158
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Estimate of the Effect of the ACE-I/D Polymorphism on Preeclampsia Risk Modeled with Logistic Regression
###end p 158
###begin p 159
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Characteristics of Published Studies of the Association between the ACE-I/D Polymorphism and Preeclampsia Included in the Meta-Analysis
###end p 159
###begin p 160
Extended.
###end p 160
###begin p 161
Extended.
###end p 161
###begin p 162
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Characteristics of Published Studies of the Association between the ACE-I/D Polymorphism and Preeclampsia Included in the Meta-Analysis
###end p 162
###begin p 163
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE-I/D</italic>
Genotypic ORs for Preeclampsia and the ACE-I/D Variant.
###end p 163
###begin p 164
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 184 192 <span type="species:ncbi:9606">patients</span>
Author contributions. NCS, LAD, MCP, RC, AM, LS, ADH, and JPC designed the study. NCS, LAD, MCP, CMM, AM, AG, LS, and JPC analyzed the data. NCS, MCP, CMM, RC, AM, AG, and LS enrolled patients. NCS, LAD, MCP, CMM, AM, AG, LS, ADH, and JPC contributed to writing the paper. MCP genotyped the insertion/deletion within the angiotensin-converting enzyme gene and collected the data for the meta-analysis.
###end p 164
###begin p 165
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: This project was funded by a grant from Universidad Autonoma de Bucaramanga (EGEN-10) awarded to NCS. LS holds a Medical Research Council Clinician Scientist Fellowship. ADH holds a British Heart Foundation Senior Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 165
###begin p 166
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: University College London holds patents on the measurement of asymmetric dimethylarginine in the management of preeclampsia.
###end p 166

